Literature DB >> 26593270

Oligodeoxynucleotide inhibition of Toll-like receptors 3, 7, 8, and 9 suppresses cytokine production in a human rheumatoid arthritis model.

Sandra Sacre1, Alexandra Lo2, Bernard Gregory2, Matthew Stephens1, Giselle Chamberlain1, Philip Stott3, Fionula Brennan2.   

Abstract

Toll-like receptors (TLRs) are innate immune receptors that respond to both exogenous and endogenous stimuli and are suggested to contribute to the perpetuation of chronic inflammation associated with rheumatoid arthritis (RA). In particular, the endosomal TLRs 3, 7, 8, and 9 have more recently been postulated to be of importance in RA pathogenesis. In this study, pan inhibition of the endosomal TLRs by a phosphorothioate-modified inhibitory oligodeoxynucleotide (ODN) is demonstrated in primary human B cells, macrophages, and RA fibroblasts. Inhibition of TLR8 was of particular interest as TLR8 has been associated with RA pathogenesis in both human and murine arthritis models. ODN1411 competitively inhibited TLR8 signaling and was observed to directly bind to a purified TLR8 ectodomain, suggesting inhibition was through a direct interaction with the receptor. Addition of ODN1411 to human RA synovial membrane cultures significantly inhibited spontaneous cytokine production from these cultures, suggesting a potential role for one or more of the endosomal TLRs in inflammatory cytokine production in RA and the potential for inhibitory ODNs as novel therapies.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cytokines; Inflammation; Oligodeoxynucleotide; Rheumatoid arthritis; TNF; Toll-like receptor

Mesh:

Substances:

Year:  2015        PMID: 26593270     DOI: 10.1002/eji.201546123

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Mincle-binding DNA aptamer demonstrates therapeutic potential in a model of inflammatory bowel disease.

Authors:  Matthew Stephens; Keith Keane; Simon Roizes; Shan Liao; Pierre-Yves von der Weid
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-02       Impact factor: 10.183

2.  CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes.

Authors:  Chao Yang; Mahesh Bachu; Yong Du; Caroline Brauner; Ruoxi Yuan; Marie Dominique Ah Kioon; Giancarlo Chesi; Franck J Barrat; Lionel B Ivashkiv
Journal:  Nat Commun       Date:  2022-06-14       Impact factor: 17.694

3.  Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.

Authors:  Xiaoyu Wang; Yu Chen; Steven Zhang; Jinxia Nancy Deng
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

4.  Small-Molecule TLR8 Antagonists via Structure-Based Rational Design.

Authors:  Zhenyi Hu; Hiromi Tanji; Shuangshuang Jiang; Shuting Zhang; Kyoin Koo; Jean Chan; Kentaro Sakaniwa; Umeharu Ohto; Albert Candia; Toshiyuki Shimizu; Hang Yin
Journal:  Cell Chem Biol       Date:  2018-08-09       Impact factor: 8.116

Review 5.  Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology.

Authors:  Sarah Unterberger; Kevin A Davies; Srinivasa Bhargav Rambhatla; Sandra Sacre
Journal:  Immunotargets Ther       Date:  2021-07-28

6.  The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.

Authors:  Belinda S Hall; Louise Tzung-Harn Hsieh; Sandra Sacre; Rachel E Simmonds
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

Review 7.  Host-pathogen protein-nucleic acid interactions: A comprehensive review.

Authors:  Anuja Jain; Shikha Mittal; Lokesh P Tripathi; Ruth Nussinov; Shandar Ahmad
Journal:  Comput Struct Biotechnol J       Date:  2022-08-04       Impact factor: 6.155

Review 8.  Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments.

Authors:  Laura Duffy; Steven C O'Reilly
Journal:  Immunotargets Ther       Date:  2016-08-22

Review 9.  Pattern recognition receptors in health and diseases.

Authors:  Danyang Li; Minghua Wu
Journal:  Signal Transduct Target Ther       Date:  2021-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.